Selected article for: "absolute reduction and risk reduction"
Title: 2017 ACVIM Forum Research Abstract Program
  • Document date: 2017_6_15
    • ID: ri2w5iby_393
    Snippet: Sixty-five dogs were included in this study. Dogs were divided into the prednisolone (PDL) or non-prednisolone (NPDL) groups. Prednisolone was administered at a dose of 1 mg/kg/day in the PDL group. Enrofloxacin, maropitant, famotidine, fentanyl, and IV fluids were used as treatments in both groups. The number of days until the CRP level < 2 mg/dl, the clinical sign score (APCS) < 2, duration of hospitalization, mortality, and relapse rate were a.....
    Document: Sixty-five dogs were included in this study. Dogs were divided into the prednisolone (PDL) or non-prednisolone (NPDL) groups. Prednisolone was administered at a dose of 1 mg/kg/day in the PDL group. Enrofloxacin, maropitant, famotidine, fentanyl, and IV fluids were used as treatments in both groups. The number of days until the CRP level < 2 mg/dl, the clinical sign score (APCS) < 2, duration of hospitalization, mortality, and relapse rate were analyzed. Treatment effect was assessed using relative and absolute risk reduction (RRR, ARR) and number needed to treat (NNT).

    Search related documents:
    Co phrase search for related documents
    • absolute relative risk reduction and group treatment: 1, 2
    • absolute relative risk reduction and risk reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • absolute relative risk reduction and treatment effect: 1
    • ARR RRR absolute relative risk reduction and risk reduction: 1, 2, 3
    • ARR RRR absolute relative risk reduction and treatment effect: 1
    • clinical sign score and sign score: 1
    • crp level and group treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • crp level and NPDL group: 1
    • crp level and PDL group: 1
    • crp level and PDL group day: 1
    • crp level and relapse rate: 1
    • crp level and study include: 1, 2
    • crp level and treatment effect: 1, 2, 3, 4, 5, 6
    • day number and group treatment: 1, 2, 3, 4, 5, 6, 7, 8
    • day number and NNT treat: 1
    • day number and risk reduction: 1, 2, 3, 4
    • day number and treatment effect: 1, 2, 3